Enovis (ENOV) Share-based Compensation Growth (1y) (2011 - 2026)
Enovis (ENOV) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 153.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 153.84% |
| Dec 31, 2025 | 474.22% |
| Oct 3, 2025 | 81.30% |
| Jul 4, 2025 | -87.75% |
| Apr 4, 2025 | -27.77% |
| Jun 28, 2024 | 12,403.70% |
| Mar 29, 2024 | 469.45% |
| Jun 30, 2023 | -108.43% |
| Mar 31, 2023 | -91.50% |
| Dec 31, 2022 | 88.90% |
| Sep 30, 2022 | -97.02% |
| Jul 1, 2022 | 5.09% |
| Apr 1, 2022 | 26.26% |
| Dec 31, 2021 | -3,543.82% |
| Oct 1, 2021 | 3,758.26% |
| Jul 2, 2021 | 10.44% |
| Apr 2, 2021 | 27.48% |
| Dec 31, 2020 | 142.75% |
| Oct 2, 2020 | 19.21% |
| Jul 3, 2020 | 44.34% |